|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/17/2024 |
$2.17 |
$2.22 |
$2.12 |
$2.15 |
1.26M | 04/18/2024 |
$2.15 |
$2.19 |
$1.99 |
$2.00 |
1.92M | 04/19/2024 |
$2.02 |
$2.09 |
$1.95 |
$2.07 |
2.88M | 04/22/2024 |
$2.07 |
$2.19 |
$2.04 |
$2.18 |
1.50M | 04/23/2024 |
$2.14 |
$2.25 |
$2.10 |
$2.18 |
811.20K |
|
Coherus BioSciences is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of immunotherapies to treat cancer. Co. in-licensed its lead immuno-oncology product candidate, toripalimab (CHS-007), an anti-PD-1 antibody, from Shanghai Junshi Biosciences Co., Ltd. Toripalimab is being evaluated in late-stage clinical trials for the treatment of a range of tumor types. Co.'s commercial portfolio includes two U.S. Food and Drug Administration-approved biologics, including UDENYCA® (pegfilgrastim-cbqv), a biosimilar to Neulasta®, a granulocyte-colony stimulating factor and YUSIMRY (adalimumab-aqvh), its Humira® (adalimumab) biosimilar product. | |
|
Coherus BioSciences (CHRS) has the following price history information. Looking back at CHRS historical stock prices for the last five trading days, on April 17, 2024, CHRS opened at $2.17, traded as high as $2.22 and as low as $2.12, and closed at $2.15. Trading volume was a total of 1.26M shares. On April 18, 2024, CHRS opened at $2.15, traded as high as $2.19 and as low as $1.99, and closed at $2.00. Trading volume was a total of 1.92M shares. On April 19, 2024, CHRS opened at $2.02, traded as high as $2.09 and as low as $1.95, and closed at $2.07. Trading volume was a total of 2.88M shares. On April 22, 2024, CHRS opened at $2.07, traded as high as $2.19 and as low as $2.04, and closed at $2.18. Trading volume was a total of 1.50M shares. On April 23, 2024, CHRS opened at $2.14, traded as high as $2.25 and as low as $2.10, and closed at $2.18. Trading volume was a total of 811.20K shares.
CHRS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Coherus BioSciences shares, starting with a $10,000 purchase of CHRS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/21/2014 |
|
End date: |
04/23/2024 |
|
Start price/share: |
$13.05 |
|
End price/share: |
$2.18 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-83.30% |
|
Average Annual Total Return: |
-17.29% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,671.14 |
|
Years: |
9.42 |
|
|
|
Date |
Close |
04/17/2024 | $2.15 | 04/18/2024 | $2.00 | 04/19/2024 | $2.07 | 04/22/2024 | $2.18 | 04/23/2024 | $2.18 |
|
|